US.EW · Edwards Lifesciences

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.0768631813125693,
        "turnoverUsdM": 236.91347000000002,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.EW",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 86.1658,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.2,
      "take_profit_price": 94.395,
      "target_multiplier": 1.6,
      "technical_strength": 1.48,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.203738417867281,
    "stopLossPercent": 4.153726362625139,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 54.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 91.0445,
    "ma50": 89.6368,
    "close": 89.9,
    "prevClose": 89.78,
    "avgVolume20": 2805810,
    "volumeRatio": 0.94,
    "changePercent": 0.13
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.0034364261168383647,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.942476159140531,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.9795675845062205,
      "volat_points": 0,
      "day_range_pct": 0.0201334816462735,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 54.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 54,
        "contribution": 2.7
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 7.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 52,
        "contribution": 7.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 18.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 60.33,
        "contribution": 18.1
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 51.8,
    "details": [
      "基本面分析總分: 2.7/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 7.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 18.1/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 10,
      "市場環境": 7.8,
      "情緒分析": 4,
      "技術信號": 18.1,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 236.91347000000002,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.EW",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 717.5105010500001,
                "ma50": 711.0850000400001,
                "name": "QQQ",
                "close": 718.96002,
                "points": 2
              },
              "spy": {
                "ma20": 769.0529934000002,
                "ma50": 756.85720062,
                "name": "SPY",
                "close": 770.19,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.0768631813125693,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 1
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141363799,
                "url": "https://finnhub.io/api/news?id=333be4e944228107f46e82eb4c189a5712c79cf2a54bcdd91358dfdbbae466ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "An unusually high volume of out-of-the-money (OTM) put options in Edwards Lifesciences (EW) shows investors are bullish on EW stock over the next three months. Moreover, EW is below analysts' price targets.",
                "category": "company",
                "datetime": 1788201002,
                "headline": "Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock"
              },
              {
                "id": 141363800,
                "url": "https://finnhub.io/api/news?id=132ff0d47621e88db46c1e729e50927f8e2bf5baad2df7f08e374cd83482bbe8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming the 13.87% gain for the Russell 1000 Value Index and the 15.20% return for the S&P 500, while […]",
                "category": "company",
                "datetime": 1787938897,
                "headline": "Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom"
              },
              {
                "id": 141281699,
                "url": "https://finnhub.io/api/news?id=fbaa0fb465cb7b5e94846908c161eb264c0d032f7d5847c1fe48539bec4bf65b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) recently held its annual Asia Pacific Patient Experience event, spotlighting patient and caregiver perspectives on structural heart disease. For investors, the gathering raises questions about how patient engagement connects to Edwards Lifesciences stock. See our latest analysis for Edwards Lifesciences. At a share price of $89.83, Edwards Lifesciences has seen a 6.24% 30 day share price return and a 4.72% 90 day share price return, while the 1 year total shareholder...",
                "category": "company",
                "datetime": 1787271133,
                "headline": "Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?"
              },
              {
                "id": 141281712,
                "url": "https://finnhub.io/api/news?id=7cbf6a4bd23762f011394fe6ea8002bc11c79ee562a732acfa1f89a8c4684880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock has delivered a 21.6% gain over the past three years, yet the valuation checks paint a less generous picture. The intrinsic value estimate from a Discounted Cash Flow (DCF) model indicates the shares are roughly fairly valued, while traditional market multiples lean expensive. Over the last three years, Edwards Lifesciences has returned 21.6%, which rewards patient holders but leaves fresh buyers needing to judge how much upside is left at today’s...",
                "category": "company",
                "datetime": 1787213454,
                "headline": "Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings"
              },
              {
                "id": 141226765,
                "url": "https://finnhub.io/api/news?id=944238222c9a941c04cbf9bb360c8aaf00f754e3da0e49ccc10edebf065198f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.",
                "category": "company",
                "datetime": 1786725420,
                "headline": "Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?"
              }
            ],
            "raw_source": [
              {
                "id": 141758077,
                "url": "https://finnhub.io/api/news?id=f0abeae7b345fcf63f4ae44fa3cce64a78b15eb65c0eec0d640baaff2b2fd7c4",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2249179691/image_2249179691.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "Baron Asset Fund initiated a position in Edwards Lifesciences due to its dominant heart valve market share. Read the full analysis for more details.",
                "category": "company",
                "datetime": 1788750600,
                "headline": "Edwards Lifesciences: $20 Billion TAM And A Meaningful Opportunity To Compound"
              },
              {
                "id": 141437930,
                "url": "https://finnhub.io/api/news?id=363996b5598cdc6cbd4a9ff5b8357ca4a6e2dfb3b9ccf4040974e9945cfc3d7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535817,
                "headline": "Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141381180,
                "url": "https://finnhub.io/api/news?id=aff4cd1f434fbbb0d65c87f29c8c7560f83d23928031121fd5c2ed58c880051b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., September 02, 2026--Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.",
                "category": "company",
                "datetime": 1788383700,
                "headline": "Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit"
              },
              {
                "id": 141370018,
                "url": "https://finnhub.io/api/news?id=059db278a5816d8a3090601824208a14b78b68eed829ec97b66edee7c3671c73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intuitive Surgical is boosting R&D despite macro headwinds, targeting AI, robotics and new procedures to expand its market and drive long-term growth.",
                "category": "company",
                "datetime": 1788278520,
                "headline": "Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?"
              },
              {
                "id": 141363799,
                "url": "https://finnhub.io/api/news?id=333be4e944228107f46e82eb4c189a5712c79cf2a54bcdd91358dfdbbae466ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "An unusually high volume of out-of-the-money (OTM) put options in Edwards Lifesciences (EW) shows investors are bullish on EW stock over the next three months. Moreover, EW is below analysts' price targets.",
                "category": "company",
                "datetime": 1788201002,
                "headline": "Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock"
              },
              {
                "id": 141363800,
                "url": "https://finnhub.io/api/news?id=132ff0d47621e88db46c1e729e50927f8e2bf5baad2df7f08e374cd83482bbe8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming the 13.87% gain for the Russell 1000 Value Index and the 15.20% return for the S&P 500, while […]",
                "category": "company",
                "datetime": 1787938897,
                "headline": "Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom"
              },
              {
                "id": 141363801,
                "url": "https://finnhub.io/api/news?id=2442e1edfe615223b69eb20cffdf7b2349955f48d2cd226ea6fb87f61c0f9bbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787848214,
                "headline": "Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?"
              },
              {
                "id": 141331543,
                "url": "https://finnhub.io/api/news?id=5ec2d4c75b529299477c3b76fd4b9480a3d4fae681248ea808c3d10437c3ab15",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Disclosed in a recent SEC filing on August 26, Chopra, CVP at Edwards Lifesciences (NYSE:EW), made a noteworthy transaction involving the exercise of company stock options.\nWhat Happened: The latest Form 4 filing on",
                "category": "company",
                "datetime": 1787828534,
                "headline": "Insider Move: Daveen Chopra Exercises Options, Realizing $551K At Edwards Lifesciences"
              },
              {
                "id": 141363802,
                "url": "https://finnhub.io/api/news?id=68028d659d2abf6b0bc009ee2e138ce5f9690d34020cbc1d8cf904591ff5838d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Medtronic's Q1 results may reflect strong growth across Cardiovascular, Neuroscience and Diabetes, but earnings beat signals remain mixed.",
                "category": "company",
                "datetime": 1787755980,
                "headline": "MDT's Q1 Earnings on Deck: How Should You Play the Stock Now?"
              },
              {
                "id": 141279655,
                "url": "https://finnhub.io/api/news?id=4022a61f18744248d075fbe3cc8738debb8f01b33118af64b4cac3ad000ade69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.",
                "category": "company",
                "datetime": 1787331660,
                "headline": "Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?"
              },
              {
                "id": 141281699,
                "url": "https://finnhub.io/api/news?id=fbaa0fb465cb7b5e94846908c161eb264c0d032f7d5847c1fe48539bec4bf65b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) recently held its annual Asia Pacific Patient Experience event, spotlighting patient and caregiver perspectives on structural heart disease. For investors, the gathering raises questions about how patient engagement connects to Edwards Lifesciences stock. See our latest analysis for Edwards Lifesciences. At a share price of $89.83, Edwards Lifesciences has seen a 6.24% 30 day share price return and a 4.72% 90 day share price return, while the 1 year total shareholder...",
                "category": "company",
                "datetime": 1787271133,
                "headline": "Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?"
              },
              {
                "id": 141279658,
                "url": "https://finnhub.io/api/news?id=ccdd2318d04922d45cc700e03560485e831e0d06bfb5bd3eddc8df398c53b11c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.",
                "category": "company",
                "datetime": 1787240760,
                "headline": "Should Investors Buy STERIS as Growth Meets Reasonable Valuation?"
              },
              {
                "id": 141281711,
                "url": "https://finnhub.io/api/news?id=33fb2f7d230305748eb64361fcd64ac85f4c63044989f61841a0253cd5a060e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "EW's TAVR and TMTT growth support its outlook, but currency pressure and intense competition remain key risks.",
                "category": "company",
                "datetime": 1787240640,
                "headline": "Should You Hold Edwards Lifesciences Stock in Your Portfolio?"
              },
              {
                "id": 141281712,
                "url": "https://finnhub.io/api/news?id=7cbf6a4bd23762f011394fe6ea8002bc11c79ee562a732acfa1f89a8c4684880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock has delivered a 21.6% gain over the past three years, yet the valuation checks paint a less generous picture. The intrinsic value estimate from a Discounted Cash Flow (DCF) model indicates the shares are roughly fairly valued, while traditional market multiples lean expensive. Over the last three years, Edwards Lifesciences has returned 21.6%, which rewards patient holders but leaves fresh buyers needing to judge how much upside is left at today’s...",
                "category": "company",
                "datetime": 1787213454,
                "headline": "Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings"
              },
              {
                "id": 141257577,
                "url": "https://finnhub.io/api/news?id=59a8c98036ebd53aa47d15b1c10d92f5707d3dbbb713613742e196709dbde0eb",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 7.93% on an annualized basis producing an average annual return of 17.22%. Currently, Edwards Lifesciences has a market capitalization",
                "category": "company",
                "datetime": 1787140833,
                "headline": "Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years"
              },
              {
                "id": 141265012,
                "url": "https://finnhub.io/api/news?id=6306299bf8c0083ad7ed7398a1dda29d79bf659716d1cdeed57bf18c43632e5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN™ AI as a globally recognized healthcare AI platformThe broader 2026 International Prix Galien nominee field includes innovations from many of the world's leading pharmaceutical, biotechnology and medical technology companies, including AstraZeneca, Merck & Co. (MSD), Johnson & Johnson, Pfizer, Sanofi, Regeneron, Roche, Novo...",
                "category": "company",
                "datetime": 1787139000,
                "headline": "HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global \"Best of the Best\" in Life Sciences Innovation"
              },
              {
                "id": 141281702,
                "url": "https://finnhub.io/api/news?id=9ee0f935c15acfa81f3ddf768978842481802bbaccf219995d7b80d62e8f8366",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "As structural heart disease continues to impact a growing number of people across Asia Pacific amid a rapidly ageing population, Edwards Lifesciences (Edwards) brought together patients for its annual Asia-Pacific Patient Experience event. The programme created a platform for patients, caregivers, healthcare professionals and employees to share perspectives, foster meaningful connections and deepen understanding of the patient journey.",
                "category": "company",
                "datetime": 1787133600,
                "headline": "Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care"
              },
              {
                "id": 141251970,
                "url": "https://finnhub.io/api/news?id=4364ba6127479c07f5699a16fac7cbec7765cc2acfb197a9f0960759f80cbeac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Gary Sorsher has been named executive vice president and chief quality officer, effective September 8.",
                "category": "company",
                "datetime": 1787002200,
                "headline": "BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire"
              },
              {
                "id": 141226765,
                "url": "https://finnhub.io/api/news?id=944238222c9a941c04cbf9bb360c8aaf00f754e3da0e49ccc10edebf065198f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.",
                "category": "company",
                "datetime": 1786725420,
                "headline": "Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?"
              },
              {
                "id": 141219196,
                "url": "https://finnhub.io/api/news?id=d589796c49ee8c58aad29f907397207bc3d2821e4436174cdabb2cfa8eb12a60",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1786714524,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141216725,
                "url": "https://finnhub.io/api/news?id=75b3ea82141ce5c2d9b288a912788b857b5a70b3f29d76f59065d6a21564acbb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1282122168/image_1282122168.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "Boston Scientific (BSX) stock: EP/WATCHMAN slowdown drives discount valuation. See why it’s a Buy—new launches, insider buying, cost savings.",
                "category": "company",
                "datetime": 1786705872,
                "headline": "Boston Scientific: A Deep Dive Into The Headwinds And Why I See A Recovery Ahead"
              },
              {
                "id": 141220590,
                "url": "https://finnhub.io/api/news?id=6ee2ff0112658e580c4563d0a8c6ffbb026313e5cc042f656138199849bc8dc6",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 15.06%. Currently, Edwards Lifesciences has a market capitalization",
                "category": "company",
                "datetime": 1786643145,
                "headline": "$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 141205611,
                "url": "https://finnhub.io/api/news?id=dd5eca2ade8f4181ead20a9e255e7c1a5afce1573708bd3d80f4816f41e5a7fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.",
                "category": "company",
                "datetime": 1786625460,
                "headline": "Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation"
              },
              {
                "id": 141202085,
                "url": "https://finnhub.io/api/news?id=8688db89e262b9bd5d93cb3731e971b1f24a8c364cc2fc621a4f9c938d2f806a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Though Edwards Lifesciences has underperformed the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook on the stock’s prospects.",
                "category": "company",
                "datetime": 1786539674,
                "headline": "Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?"
              },
              {
                "id": 141192888,
                "url": "https://finnhub.io/api/news?id=8bfe3da79a9d72b2c4f660fa91d74daddc52a60efc7a41079b049140729b94ef",
                "image": "",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "",
                "category": "company",
                "datetime": 1786528125,
                "headline": "Edwards Lifesciences: Strong Execution, But Little Room For Error At $90"
              },
              {
                "id": 141191790,
                "url": "https://finnhub.io/api/news?id=3b4a18b4d28df314a1c8e3ba7b6ed1d79058f97d4fb702b12e7d1f1b737ab971",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182459087/image_1182459087.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "Edwards Lifesciences' Q2 saw 13.6% YoY sales growth, but Q3 guidance implies a sequential decline attributed to tough comps, not demand. Read more on EW stock here.",
                "category": "company",
                "datetime": 1786506905,
                "headline": "Edwards Lifesciences: Cheap Against Itself, Expensive Against Everything Else"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1,
            "source_article_count": 26,
            "discarded_article_count": 21
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.1,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(14.2%→4.6%)；跌縮量(近10日4日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 3560123.3333333335,
              "down_days": 4,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 2683880,
              "avg_vol_20": 2796145,
              "avg_vol_30": 3560123.3333333335,
              "range_pct_10": 0.04627363737486091,
              "range_pct_20": 0.05895439377085647,
              "range_pct_30": 0.1418242491657397,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7538727590898068,
              "dist_to_20d_high": 0.042700457885209146,
              "down_shrink_days": 4,
              "breakout_level_20d": 93.91,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.32627450980392125
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.0768631813125693,
              "turnoverUsdM": 236.91347000000002,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.EW",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 86.1658,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.2,
            "take_profit_price": 94.395,
            "target_multiplier": 1.6,
            "technical_strength": 1.48,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.203738417867281,
          "stopLossPercent": 4.153726362625139,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.EW",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 1.8671,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.08
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -130.44
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0292
    },
    "kdj": {
      "d": 36.59,
      "j": 26.21,
      "k": 33.13,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 54.14
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 14261000,
      "recentSlope": 349170,
      "previousSlope": -368180
    },
    "rsi": 44.32,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 92.1386,
      "position": "SAR喺價上",
      "distancePct": 2.49,
      "previousTrend": "下降"
    },
    "ma50": 89.6368,
    "macd": {
      "macd": 0.31280247678418505,
      "trend": "中性偏多",
      "signal": 0.521110290115053,
      "histogram": -0.208307813330868
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 91.1123,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.94,
      "score": 4,
      "avgVolume": 2805810,
      "currentVolume": 2635300
    },
    "derived": {
      "ma20": 91.0445,
      "ma50": 89.6368,
      "prevClose": 89.78,
      "avgVolume10": 2665430,
      "avgVolume20": 2805810,
      "changePercent": 0.13,
      "avgVolumeForScore": 2805810
    },
    "ma_cross": {
      "ma20": 91.0445,
      "ma50": 89.6368,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 91.0355,
      "prevMa50": 89.6332,
      "spreadPct": 1.57,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 88.8307,
      "upper": 93.2583,
      "position": "中間"
    },
    "rsi_short": 48.78,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.94
    }
  }
}

{
  "close": 89.9,
  "volume": 2635300,
  "changePercent": 0.13
}